← Leaderboards
Leslie Hendeles
University Of Florida
$383,306
Attributed
$383,306
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $24.7K · FY2005–09$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$383,306 · 6
By mechanism
M01$383,306 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Mark A Atkinson$38,540,675
- Phillip P Toskes$1,841,794
- Westley H Reeves$15,299,965
- Edward K Chan$5,663,390
- L T Spencer$1,014,888
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationRespiratory Disorder ChemotherapyDrug Screening /EvaluationInhalation Drug AdministrationAsthmaDosage FormsClinical TrialsAlbuterolAntigen Antibody ReactionCystic Fibrosis PatientsClinical Trial Phase ISourceAdult Human (21+)Research PersonnelResourcesInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseOpen LabelFundingGrantSafetyUnited States National Institutes Of Health
Grant awards (9)
PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED ALTU-135 IN PATIENT STUD$22,445
M01 · FY2009 · RR · contact PI
OPEN LABEL STUDY OF LONG-TERM SAFETY OF ALTU-135- OUTPATIENT STUDY$2,224
M01 · FY2009 · RR · contact PI
SYSTEMIC EXPOSURE TO FLUTICASONE IN PRE-SCHOOL CHILDREN WITH ASTHMA$13,012
M01 · FY2005 · RR
Tolerability of Oral TheraCLEC-Total in Subjects with CF$44,212
M01 · FY2004 · RR
DOSE-RESPONSE FOR BRONCHODILATION RESULTING FROM ALBUTEROL IN NOCTURNAL ASTHMA$207,281
M01 · FY2001 · RR
DOSE-RESPONSE FOR BRONCHODILATION RESULTING FROM ALBUTEROL IN NOCTURNAL ASTHMA$55,741
M01 · FY2001 · RR
DOSE-RESPONSE FOR BRONCHODILATION RESULTING FROM ALBUTEROL IN NOCTURNAL ASTHMA$38,391
M01 · FY2000 · RR
PHASE I TRIAL OF L808065 IN ANTIGEN CHALLENGE OF ASTHMA PATIENTS$0
M01 · FY2000 · RR
PHASE I TRIAL OF L808065 IN ANTIGEN CHALLENGE OF ASTHMA PATIENTS$0
M01 · FY2000 · RR